| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3250607 | The Journal of Emergency Medicine | 2008 | 5 Pages |
Abstract
Clopidogrel (Plavix), a platelet aggregation inhibitor, has been shown to be effective in certain patients undergoing percutaneous coronary interventions, but its use in patients with acute myocardial infarction who receive a fibrinolytic strategy instead has been controversial. The aim of the Evidence-Based Medicine (EBM) Section is to bring the readership clinically relevant and practical evidence-based medicine principles and topic reviews. This EBM – Therapy review focuses on a relatively new therapy option for Emergency Department patients with acute myocardial infarction.
Related Topics
Health Sciences
Medicine and Dentistry
Emergency Medicine
Authors
Andrew Worster, Samuel M. Keim, Rajiv Vadera, Peter Rosen,